drugset
drugset / Trial / NCT01190657

Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer

NCT01190657 ↗

Phase 4 Completed 1184 enrolled Eisai Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is a self-controlled, open, multiple-center clinical trial.

Timeline

Start
2010-05
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Teprenone Unknown 50 mg —

Indications

gastric ulcer gastritis